Matthew P Connor

8PUBLICATIONS
60CO-AUTHORS
PhysiotherapyHaematological tumoursGene and molecular therapyAutoimmunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 25, 2026
Improved Outcomes with TKI Maintenance Following Brexucabtagene Autoleucel in Philadelphia-chromosome ALL.

|Feb 05, 2026
Blinatumomab nonresponse correlates with poor survival after brexucabtagene autoleucel in B-cell ALL.

Hrishikesh Krishna Srinagesh, Vishal K Gupta, Amy Zhang

|Oct 06, 2025
CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia.

Yannis K Valtis, Chenyu Lin, David Nemirovsky

|Aug 23, 2025
The impact of social determinants of health on outcomes of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia.

Timothy E O'Connor, Chenyu Lin, Gregory W Roloff

|May 07, 2025
Outcomes of brexucabtagene autoleucel in patients with relapsed/refractory acute lymphoblastic leukemia with CNS involvement.

Ibrahim N Muhsen, Gregory W Roloff, Rawan Faramand

|Oct 17, 2024
Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL.

Gregory W Roloff, Ibrahim Aldoss, Noam E Kopmar

Pageof 2

Frequent Collaborators

7 joint publications

Aaron C Logan

7 joint publications

Lori S Muffly

7 joint publications

Joshua Sasine

6 joint publications

Noelle V Frey